Vischer advises Norgine Ventures in the financing of Lunaphore
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be drawn down in multiple tranches.
Based in Lausanne, Lunaphore Technologies has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity.
Started in 2012, Norgine Ventures is a leading provider of financing for innovative healthcare companiesis, a business entity of Norgine. The company provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US.
VISCHER is advising Norgine Ventures with a team composed by partners Matthias Staehelin (corporate/m&a, pictured) and partner Adrian Dörig, both corporate/M&A, as well as Christian Schneiter (senior associate, corporate/m&a).
